All In MedTech

FDA Clearance Tracker · P010007-S025

IMMULITE 2000 AFP

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P010007-S025
Device name
IMMULITE 2000 AFP
Applicant location
Tarrytown, NY
Received
Sep 30, 2025
Decided
Apr 21, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P010007

Device type

Device class
Class III

Every decision under product code LOK

FDA's approval statement

As written in FDA's record.

approval of the instrument manufacturing site change for the IMMULITE 2000XPi analyzer to the Siemens Healthcare Diagnostics instrument manufacturing facility located in Llanberis, Wales

Source documents

Other decisions for Siemens Healthcare Diagnostics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.